Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP640223.RAPHMKQWvORRVfhZva4WL3M3seAiKglrnEc3shdmERA94130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP640223.RAPHMKQWvORRVfhZva4WL3M3seAiKglrnEc3shdmERA94130_assertion type Assertion NP640223.RAPHMKQWvORRVfhZva4WL3M3seAiKglrnEc3shdmERA94130_head.
- NP640223.RAPHMKQWvORRVfhZva4WL3M3seAiKglrnEc3shdmERA94130_assertion description "[Treatment of AML-193 cells with anti-gp130 antibodies alone also led to a notable decline in GM-CSF binding activity, suggesting a possible role of gpl30 in regulating the expression of GM-CSF receptors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP640223.RAPHMKQWvORRVfhZva4WL3M3seAiKglrnEc3shdmERA94130_provenance.
- NP640223.RAPHMKQWvORRVfhZva4WL3M3seAiKglrnEc3shdmERA94130_assertion evidence source_evidence_literature NP640223.RAPHMKQWvORRVfhZva4WL3M3seAiKglrnEc3shdmERA94130_provenance.
- NP640223.RAPHMKQWvORRVfhZva4WL3M3seAiKglrnEc3shdmERA94130_assertion SIO_000772 8641372 NP640223.RAPHMKQWvORRVfhZva4WL3M3seAiKglrnEc3shdmERA94130_provenance.
- NP640223.RAPHMKQWvORRVfhZva4WL3M3seAiKglrnEc3shdmERA94130_assertion wasDerivedFrom befree-20140225 NP640223.RAPHMKQWvORRVfhZva4WL3M3seAiKglrnEc3shdmERA94130_provenance.
- NP640223.RAPHMKQWvORRVfhZva4WL3M3seAiKglrnEc3shdmERA94130_assertion wasGeneratedBy ECO_0000203 NP640223.RAPHMKQWvORRVfhZva4WL3M3seAiKglrnEc3shdmERA94130_provenance.